Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 26 Artikel )

16.10.2019 | Editorial | Ausgabe 3/2019

BCRT: a brief valedictory

Marc Lippman

26.08.2019 | Review | Ausgabe 3/2019

Obstetrical outcomes in women with history of breast cancer: a systematic review and meta-analysis

Valentina D’Ambrosio, Flaminia Vena, Daniele Di Mascio, Ida Faralli, Lucia Musacchio, Chiara Boccherini, Roberto Brunelli, Maria Grazia Piccioni, Pierluigi Benedetti Panici, Antonella Giancotti

27.08.2019 | Review | Ausgabe 3/2019

The microbiome and breast cancer: a review

Jennifer Chen, Jacqueline Douglass, Vishnu Prasath, Meghan Neace, Siavash Atrchian, Masoud H. Manjili, Shervin Shokouhi, Mehran Habibi

30.08.2019 | Review | Ausgabe 3/2019

Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis

Chao Li, Hongwei Fan, Qian Xiang, Ling Xu, Zhuo Zhang, Qianxin Liu, Tongtong Zhang, Jinjie Ling, Ying Zhou, Xia Zhao, Yimin Cui

05.09.2019 | Review | Ausgabe 3/2019

Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database

E. Kaczmarek, C. Saint-Martin, J.-Y. Pierga, E. Brain, R. Rouzier, A. Savignoni, E. Mouret-Fourme, V. Dieras, I. Piot, C. Dubot, M. Carton, F. Lerebours

06.09.2019 | Review | Ausgabe 3/2019

Home-based physical activity interventions for breast cancer patients receiving primary therapy: a systematic review

Steven S. Coughlin, Lee S. Caplan, Valerie Williams

14.09.2019 | Review | Ausgabe 3/2019 Open Access

Primary and secondary breast angiosarcoma: single center report and a meta-analysis

Yara Abdou, Ahmed Elkhanany, Kristopher Attwood, Wenyan Ji, Kazuaki Takabe, Mateusz Opyrchal

30.08.2019 | Preclinical study | Ausgabe 3/2019

CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy

Lutfi H. Alfarsi, Rokaya El Ansari, Madeleine L. Craze, Michael S. Toss, Brendah Masisi, Ian O. Ellis, Emad A. Rakha, Andrew R. Green

03.09.2019 | Preclinical study | Ausgabe 3/2019

Multiplex ddPCR assay for screening copy number variations in BRCA1 gene

Igor Oscorbin, Andrey Kechin, Uljana Boyarskikh, Maxim Filipenko

11.09.2019 | Preclinical Study | Ausgabe 3/2019

Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing

R. Scarpitta, I. Zanna, P. Aretini, G. Gambino, C. Scatena, B. Mei, M. Ghilli, E. Rossetti, M. Roncella, C. Congregati, F. Bonci, A. G. Naccarato, D. Palli, M. A. Caligo

13.09.2019 | Preclinical study | Ausgabe 3/2019

CpG methylation signature predicts prognosis in breast cancer

Tonghua Du, Bin Liu, Zhenyu Wang, Xiaoyu Wan, Yuanyu Wu

26.08.2019 | Clinical trial | Ausgabe 3/2019 Open Access

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms

Joost G. E. Verbeek, Vera Atema, Janne C. Mewes, Marieke van Leeuwen, Hester S. A. Oldenburg, Marc van Beurden, Myra S. Hunter, Wim H. van Harten, Neil K. Aaronson, Valesca P. Retèl

27.08.2019 | Clinical trial | Ausgabe 3/2019

Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing

W. Iris Zhi, Patricia Chen, Alice Kwon, Connie Chen, Steven E. Harte, Lauren Piulson, Susan Li, Sujata Patil, Jun J. Mao, Ting Bao

06.09.2019 | Clinical trial | Ausgabe 3/2019

Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?

T. G. Steenbruggen, N. I. Bouwer, C. H. Smorenburg, H. N. Rier, A. Jager, K. Beelen, A. J. ten Tije, P. C. de Jong, J. C. Drooger, C. Holterhues, J. J. E. M. Kitzen, M. -D. Levin, G. S. Sonke

06.09.2019 | Clinical trial | Ausgabe 3/2019

Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ

Laura E. G. Warren, Yu-Hui Chen, Lia M. Halasz, Jane E. Brock, Alexander Capuco, Rinaa S. Punglia, Julia S. Wong, Mehra Golshan, Jennifer R. Bellon

13.09.2019 | Clinical trial | Ausgabe 3/2019

Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study

Benno Brinkhaus, Barbara Kirschbaum, Barbara Stöckigt, Sylvia Binting, Stephanie Roll, Martin Carstensen, Claudia M. Witt

24.08.2019 | Epidemiology | Ausgabe 3/2019

Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina

Roxana Cerretini, Graciela Mercado, Josh Morganstein, Jorge Schiaffi, Mónica Reynoso, Diana Montoya, Rita Valdéz, Steven A. Narod, Mohammad R. Akbari

26.08.2019 | Epidemiology | Ausgabe 3/2019 Open Access

Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer

Anna Z. de Boer, Esther Bastiaannet, Nienke A. de Glas, Perla J. Marang-van de Mheen, Olaf M. Dekkers, Sabine Siesling, Linda de Munck, Kelly M. de Ligt, Johanneke E. A. Portielje, Gerrit Jan Liefers

26.08.2019 | Epidemiology | Ausgabe 3/2019 Open Access

A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study

Makoto Kubo, Masaaki Kawai, Hiraku Kumamaru, Hiroaki Miyata, Kenji Tamura, Masayuki Yoshida, Etsuyo Ogo, Masayuki Nagahashi, Sota Asaga, Yasuyuki Kojima, Takayuki Kadoya, Kenjiro Aogi, Naoki Niikura, Minoru Miyashita, Kotaro Iijima, Naoki Hayashi, Yutaka Yamamoto, Shigeru Imoto, Hiromitsu Jinno

28.08.2019 | Epidemiology | Ausgabe 3/2019 Open Access

Inherited variants in XRCC2 and the risk of breast cancer

Wojciech Kluźniak, Dominika Wokołorczyk, Bogna Rusak, Tomasz Huzarski, Jacek Gronwald, Klaudia Stempa, Helena Rudnicka, Aniruddh Kashyap, Tadeusz Dębniak, Anna Jakubowska, Marcin Lener, Marek Szwiec, Joanna Tomiczek-Szwiec, Joanna Jarkiewicz-Tretyn, Magdalena Cechowska, Paweł Domagała, Agata Szymiczek, Maryam Bagherzadeh, Jan Lubiński, Steven A. Narod, Mohammad R. Akbari, Cezary Cybulski, the Polish Hereditary Breast Cancer Consortium

30.08.2019 | Epidemiology | Ausgabe 3/2019

Validation of the online prediction model CancerMath in the Dutch breast cancer population

Liza A. Hoveling, Marissa C. van Maaren, Tom Hueting, Luc J. A. Strobbe, Mathijs P. Hendriks, Gabe S. Sonke, Sabine Siesling

04.09.2019 | Epidemiology | Ausgabe 3/2019

Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada

François Lagacé, Feras M. Ghazawi, Michelle Le, Elham Rahme, Evgeny Savin, Andrei Zubarev, Akram Alakel, Denis Sasseville, Linda Moreau, Sarkis Meterissian, Ivan V. Litvinov

06.09.2019 | Epidemiology | Ausgabe 3/2019 Open Access

Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis

Ye Won Jeon, Sun Hyong You, Jong Eun Lee, Hyun Jo Youn, Woosung Lim, Jai Hong Han, Chan Heun Park, Yong Seok Kim

11.09.2019 | Epidemiology | Ausgabe 3/2019 Open Access

The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors

K. M. de Ligt, M. Heins, J. Verloop, N. P. M. Ezendam, C. H. Smorenburg, J. C. Korevaar, S. Siesling

26.08.2019 | Letter to the Editor | Ausgabe 3/2019

Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism

Sora Yasri, Viroj Wiwanitkit

04.10.2019 | Acknowledgments | Ausgabe 3/2019

Acknowledgement of reviewers 2018

Aktuelle Ausgaben